z-logo
Premium
The responses of hemopoietic precursor cells in mice to bacterial cell‐wall components
Author(s) -
Staber Fritz G.,
Johnson Gregory R.
Publication year - 1980
Publication title -
journal of cellular physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.529
H-Index - 174
eISSN - 1097-4652
pISSN - 0021-9541
DOI - 10.1002/jcp.1041050116
Subject(s) - progenitor cell , haematopoiesis , biology , granulocyte , immunology , microbiology and biotechnology , megakaryocyte , eosinophil , precursor cell , stem cell , cell , biochemistry , asthma
The influence upon differnt cellular and humoral parameters of hemopoiesis of three structurally unrelated, highly purified bacterial cell‐wall components (BCWC) was investigated. The spleens of C57BL/6 mice assayed 6 days after the injection of either lipid A or outer‐membrane lipoportein, but not murein, showed a marked increase in granulocyte‐macrophage, eosinophil, and megakaryocyte progenitor cell levels. The number of pluripotent hemopoietic stem cells (CFU‐S) also increased in the spleens of mice treated with either lipid A or lipoprotein. Similar results were obtained following the injection of lipoprotein or lipid A into CBA or C57BL/6.nu mice. Genetically anemic W f /W f mice were found to have spontaneously elevated numbers of splenic progenitor cells, which increased further after the injection of lipid A. The proportions of the different splenic progenitor cell types were similar in both untreated and lipid A treated W f /W f mice, and in normal littermate controls. When tested in vitro, unfractionated or partially purified post‐lipid A serum was found to stimulate the growth of granulocyte‐macrophage progenitor cells (GM‐CFC), but no detectable stimulation of eosinohphil, megakryocyte, or erythroid progenitor cells was observed. The data suggest that the rise in splenic levels of the different progenitor cells is not mediated by the corresponding types of CSF, but more likely by proliferation and differentiation of CFU‐S.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here